Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C5H10N2O7P2.H2O |
| Molecular Weight | 290.1049 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
InChI
InChIKey=FUXFIVRTGHOMSO-UHFFFAOYSA-N
InChI=1S/C5H10N2O7P2.H2O/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7;/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14);1H2
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
543616
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
WHO-VATC |
QM05BA08
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID TEVA PHARMA (AUTHORIZED: OSTEOPOROSIS)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID TEVA PHARMA (AUTHORIZED: OSTEITIS DEFORMANS)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
WHO-ATC |
M05BB08
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOMETA (AUTHORIZED: BONES, FRACTURE)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
LIVERTOX |
1051
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID ACCORD (AUTHORIZED: FRACTURES, BONE)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ACLASTA (AUTHORIZED: OSTEITIS DEFORMANS)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID TEVA GENERICS (AUTHORIZED: OSTEITIS DEFORMANS)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
WHO-ATC |
M05BA08
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID MEDAC (AUTHORIZED: FRACTURES, BONE)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID TEVA GENERICS (AUTHORIZED: OSTEOPOROSIS)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
NDF-RT |
N0000175579
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
NCI_THESAURUS |
C2136
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EU-Orphan Drug |
Zoledronic acid
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
NCI_THESAURUS |
C67439
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID TEVA (AUTHORIZED: FRACTURES, BONE)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ACLASTA (AUTHORIZED: OSTEOPOROSIS, MENOPAUSAL)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
374112
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID MYLAN (AUTHORIZED: FRACTURES, BONE)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ACLASTA (AUTHORIZED: OSTEOPOROSIS)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
NCI_THESAURUS |
C443
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZOLEDRONIC ACID TEVA PHARMA (AUTHORIZED: OSTEOPOROSIS, POSTMENOPAUSAL)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2868
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
6XC1PAD3KF
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
DB00399
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
100000091548
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
Zoledronic Acid
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
ZOLEDRONIC ACID ACTAVIS (AUTHORIZED: FRACTURES, BONE)
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002667/human_med_001722.jsp&mid=WC0b01ac058001d124 | ||
|
165800-06-6
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
SUB21645
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
77655
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | RxNorm | ||
|
C088658
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
CHEMBL924
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
3177
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
DTXSID10168029
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
ZOLEDRONIC ACID
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
1724827
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
121586
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
II-2
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
6XC1PAD3KF
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
46557
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | |||
|
m11658
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY | Merck Index | ||
|
C1699
Created by
admin on Fri Dec 15 15:52:19 UTC 2023 , Edited by admin on Fri Dec 15 15:52:19 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD